So they didn't come firstMany high powered business people got to hear about a profitable biotech company operating within their midst who most I'm sure have never heard of MBX. Most in those circles are very interested in something new to invest in, and the fact that any of the companies that were nominated would be a pretty safe bet, or at least worth a second look. It was exposure among their piers in a positive light, and there is never anything wrong with exposure of that nature. Absolutely no downside and possibly we could pick up another shareholder or two. That's the way I see it.